CALL TODAY With fast turnaround time, easy, convenient web-based interface and clear and understandable reporting we provide you the opportunity of better patient care. At Faith Heal hca e Center, we offer a unique nd ompreh siv array of community based, health are services for our clients at the most appropriate and cost effective level of care.
413 Commonwealth Avenue - Suite 7 Catonsville, MD (21228)
INTERVIEW 1 ________________________________
INTERVIEW 2 ________________________________
It’s time to discover a new form of yourself— a new path for yourself— one that reaches well past the impulse of the moment. It’s time to wake up in a world of self-made character — of self-determination.
Single Page Ad
Single Page Ad
Call toDAY TO speak with one of our specialists Don’tGetHungUp on Prescription Medications
Suboxone is a prescription medication that combines two active components, buprenorphine and naloxone. When used in conjunction with a comprehensive treatment plan that includes AODA assessments, individual or group counseling, or psychosocial support; Suboxone has proven to be a promising alternative for chronic relapsers. Buprenorphine is the primary component in Suboxone, and is also known as a partial AFormidable Combination
agonist; it can attach to the same receptors as other opioids and reduce their effects by blocking them from the same receptors. The second key ingredient, Naloxone, is intended to help prevent potential misuse. For instance, if an individual who is actively dependent on an opiate or opioid attempts to ingest or inject Suboxone, the naloxone is likely to cause a quick onset of withdrawal symptoms.
ReadingBetween the Lines
Although Suboxone has proven to be a potentially promising asset in the fight against opiate addiction, its benefits do not come without conditions. One major drawback to utilizing Suboxone as a means of completley abstaining from opiates/opioids is the difficulty faced when trying to wean down or taper off of the medication. When used without the help of a more comprehensive treatment plan, such as individual/group counseling, psychosocial care, or peer-based support groups such as NA or AA, Suboxone is merely a chemical substitute for the very drugs the individual is trying to get away from.
AStep In The Right Direction While Suboxone alone may not be an immediate solution to the opiate/opioid epidemic, it cannot be argued that its benefits indicate a step in the right direction. Its utility, in combination with a comprehensive treatment plan promotes exposure to the benefits of recovery in the long run.
individuals can become addicted even after only taking opioid pain meds for a few days. One study found that one in five people given a 10-day supply of opioid painkillers became long-term users. More M.D. Education Needed Don Teater, M.D., medical adviser of the non-profit National Safety Council, says doctors need more education to understand the draw- backs of prescribing opioids. “Doctors get a lot of training in the physical aspects of health, but not the mental aspects,” says Teater, a family physician in North Carolina whose practice focuses on treatment of pain and the treatment of opioid use disorder. “We don’t get training in addiction. Often, a doctor will start a patient on opioid pain med- ication and continue it for awhile. Then if the doctor feels the patient is asking for too much medication, the doctor will cut them off, and abandon them. There needs to be a greater understanding of the emotional component to pain. We also need to have a better under- standing of the disease of addiction.” According to a white paper from the Council, there is little evidence that opioids are helpful when used for chronic pain.
four groups – and by similar levels: 4.3 points in the ibuprofen/acetaminophen group, 4.4 points in the oxycodone/acetaminophen group, 3.5 in the hydrocodone/acetaminophen group and 3.9 in the codeine/acetaminophen group. The researchers said the major limitation of the study is that it had the patients assess their pain only while they were in the emergency department. The study did not evaluate how the ibuprofen/acetaminophen combination would work in comparison to opioids once the patients went home. Also, the participants had a specific type of acute pain – from sprained or broken arms and legs. “Preventing new patients from becoming addicted to opioids may have a greater effect on the opioid epidemic than providing sus- tained treatment to patients already addicted to opioids, in whom it may take many years to achieve recovery,” Demetrio Kyriacou, M.D., a senior editor at JAMA and a professor of emer- gency medicine at Northwestern University, wrote in an accompanying editorial. Yet, as Kyriacou also acknowledges, “stemming the opioid addiction crisis will … require reex- amination of the long-standing assumptions that opioids are superior to
Trial evaluated effectiveness for common injuries
Four Groups of Patients The patients were randomly assigned to one of four groups. One group received a pill for their acute pain that contained a combination of ibu- profen and acetaminophen, the ingredients in Advil and Tylenol. The other groups were given a pill for their pain that contained a prescription opioid as well as acetaminophen, either oxyco- done and acetaminophen (Percocet), hydroco- done and acetaminophen (Vicodin), or codeine and acetaminophen (Tylenol No. 3). All the patients were asked to rate their pain immediately before taking the pain medication and again both one and two hours afterward (before they left the emergency department). The assessments were done using an 11-point scale (0 = no pain; 10 = worst possible pain). The study found that the intensity of pain was similar among all four groups before they took the medication, with a mean score of 8.7 on the scale. The pain then declined over time in all
As the over prescribing of opioid pain medications has become a major public health concern, health care providers have been paying more attention to over-the count- er-drugs that could be used instead, without the risk of addiction. A recent study published in the Journal of the American Medical Association (JAMA) has confirmed that OTC meds ibuprofen and acet- aminophen are just as effective as prescription opioids at reducing acute pain caused by com- mon injuries.It is one of the few “real world” studies that has made the comparison. A team of researchers led by Andrew Chang, M.D. of Albany Medical College, studied 411 patients (aged 21 to 64) who had sought med- ical care at two urban emergency departments after having sprained, strained or broken an arm or leg. (About 20 percent of the patients had fractures.)
non-opioids in most clinical situations requiring man- agement of moderate to severe pain.” Studies have shown that nearly one-third of adult patients seeking care at U.S. hospital emergency departments are given prescriptions for opioid painkillers, even if their visit was not pain-relat- ed. That is a dangerous practice, since some
“In fact, some evidence shows they may be detri- mental and increase risk of addiction and premature death,” the paper says.
There is little evidence that opioids are helpful when used for chronic pain.
It also authorizes HHS to develop grants to support people who are in recovery transition to independent living and jobs, as well as develop a pilot program to provide temporary housing for those recovering from substance abuse. of the bill provides measures to prevent synthetic opioids like fentanyl from entering the U.S. According to the Centers for Disease Control, total opioid deaths did not increase in 2017, but deaths due to fentanyl overdoses did. Data shows the drug, which is about 50 times more potent than heroin, caused nearly 30,000 fatal overdoses last year. access to medication-assisted treatment. It removes the cap on the number of patients to whom drugs like buprenorphine, a drug cravings and easing withdrawal, from 100 to 275, and expands a grant program allowing medication-assisted treatments.
strengthen the federal government’s response to the opioid crisis,” Sen. Rob Portman (R-OH), who helped put together the legislation, said in a statement after the Senate vote. “Importantly, this bill will increase access to long-term treatment and recovery while also like fentanyl from being shipped into the United States through our own Postal Service.” On the other side of the debate, Leana Wen, M.D., the former health commissioner of Baltimore (and incoming president of Planned Parenthood), said that the legislation “is simply tinkering around the edges.” Daniel Raymond, director of policy and planning for the Harm a bad thing, but I do think to some degree it’s a political document,” Raymond told the Washington Post. “When you drill down into it, it’s not that there aren’t good ideas, but it doesn’t reach the level of, this is what our nation needs right now.” and Mental Health Services Administration (SAMHSA) to allow organizations to develop opioid recovery centers in a community. It also requires the Department of Health and Human Services to determine best practices and then create a grant program implementing those policies or procedures, such as the use of recovery coaches, which has
On October 24, 2018... President Trump signed a new, bipartisan bill to combat the opioid addiction epidemic. Politicians are hailing it as a major step forward, while addiction and treatment experts say it falls far short of
A package of more than 70 bills introduced targeting the opioid crisis, the Support for Patients & Communities Act:
• Reauthorizes funding from the Cures Act, which put $500 million a year toward the opioid crisis, and makes some policy changes intended to give states more • Creates a grant program for “Comprehensive Opioid Recovery Centers,” which will attempt to serve the addiction treatment and recovery needs of their communities (in part by using what’s known as an ECHO model). • Removes restrictions on medications for opioid addiction, allowing more types of health care practitioners to prescribe the drugs.
• Expands an existing program
• Advances new initiatives to educate and raise awareness about proper pain treatment among health care providers. • Attempts to improve coordination between different federal agencies to stop illicit drugs like fentanyl at the border, and gives agencies more tools to improve detection and testing at border checks. • Increases penalties for drug manufacturers and distributors related to the over-prescribing of opioids.
responders, such as police and
naloxone, a medication that reverses opioid overdoses.
• Allows federal agencies to pursue more research projects related to addiction and pain. • Makes several changes to Medicare and Medicaid to attempt to limit the over-prescription of opioid painkillers within the programs and expand access to addiction treatment, including lifting some of the current restrictions that make it harder for Medicare and Medicaid to pay for addiction treatment.
overtly racist or sexist to another person. But less research has been done on what are known as micro-aggressions, small everyday occurrences that can rub a person the wrong way. That research is improving, but there are other factors that need to be more fully explored. While studies have looked at historical trauma in the African-American population, the concept has not been fully investigated with regards to Hispanic and Asian populations. “This notion of historic trauma could be really relevant to other groups, but it hasn't received much attention at all,” Dr. Gilbert says. “This is something we should pay attention to.” All of this adds up to the fact that treatment providers may be missing a key piece of the substance abuse puzzle.
The team found that discrimination did indeed lead to an increase in drinking frequency, quantity of alcohol consumed, and in the risk for alcohol use disorders. Researchers say drinking can represent a coping mechanism in response to the stress caused by discrimination, and several studies showed clients acknowledging this direct link themselves. But when looking at specific populations and types of discrimination, the picture becomes less clear. “The story is that generally there is good scientific support, but the evidence is mixed for different groups and for types of discrimination,” says Dr. Paul Gilbert, the study’s lead author. “We don’t really know comparing one type or one level to another.” For example, much research has been done on interpersonal discrimination where someone is
Discrimination, whether based on race, gender, or sexual orientation, has long been thought to be a contributor to substance abuse. Now a new study has confirmed the relationship between discrimination and addiction, but it’s also brought up many more questions that still need to be answered in order to improve treatment outcomes. Researchers at the University of Iowa recently completed a peer review study in which they looked at 97 previous studies on discrimination and alcohol use. Their goal was to summarize the collective knowledge researchers have uncovered throughout the years, and what they found confirmed in more detail what many had previously suspected.
But just because the intricacies of how discrimination affects drinking aren’t yet fully understood, that doesn’t mean our current knowledge base can’t be helpful. Dr. Gilbert says simply knowing that experiences with discrimination can drive drinking could inform the way treatment providers interact with clients, opening new areas of their lives to explore during treatment. “It can serve as sort of an early warning or indicator,” Dr. Gilbert says. “For treatment providers, it’s worth looking at: is there something that may be keeping folks from accessing services or affecting outcomes?”
Dr. Gilbert says treatment providers should continue to address discrimination as part of a holistic approach to recovery. He says it will be up to researchers to fill
in the gaps to find the precise ways that discrimination affects drinking behavior. “We’ve got good evidence on this level of interpersonal discrimination,” Dr. Gilbert says. “We’ve gotten the low-hanging fruit, now it’s time to start working on the stuff that’s a little further up the tree.”
“It can serve as sort of an early warning or indicator.”
“Generally there is good scientific support, but the evidence is mixed for different groups
and for types of discrimination.” - Dr.Paul Gilbert, University of Iowa
OPIATE + OPIOID ADDICITON What is the difference between Opiates and Opioids?
A Natural Pain RemedIES
SYNTHETIC PAIN MEDICATIONS
What Medications Treat Opiate & Opioid Addiction?
These medications act directly upon the opioid receptors; more specically the mu receptors. Because the effects of these medications vary at the receptor level, there can be different clinical effects during treatment.
ReVia | Depade | Vivitrol
Buprenorphine Suboxone | Subutex
A FULL AGONIST binds to the receptor and activates it by changing its shape - inducing a full receptor response.
A PARTIAL AGONIST binds to the receptor and activates it with a smaller shape change in the receptor that includes a partial receptor response.
INTERVIEW 4 ________________________________
At Faith Healthcare Center, we offer a unique and comprehensive array of community based, healthcare services for our clients at the most appropriate and cost effective level of care.
413 Commonwealth Avenue - Suite 7 Catonsville, MD 21228
INTERVIEW 5 ________________________________
INTERVIEW 6 ________________________________
413 Commonwealth Avenue - Suite 7 Catonsville, MD 21228
To Learn More about Faith Healthcare Center Visit Us Online www.faithhealthcarecenter.comPage 1 Page 2-3 Page 4-5 Page 6-7 Page 8-9 Page 10-11 Page 12-13 Page 14-15 Page 16-17 Page 18-19 Page 20-21 Page 22-23 Page 24-25 Page 26-27 Page 28-29 Page 30-31 Page 32-33 Page 34-35 Page 36
Powered by FlippingBook